Evaluating chronic disease management
Recommendations for funders and users
The report forms part of the DISMEVAL project, funded under the European Commission's 7th Framework Programme. It is targeted at policymakers, programme operators and researchers, explaining choices, options and trade-offs for the evaluation of disease management based on analyses undertaken within the project. Many of the issues discussed can be seen to apply to any evaluation of complex interventions in healthcare. However, there are specific concerns around evaluation design and metrics that are of relevance to the evaluation of disease management in particular and that are examined in the report. These include (i) the context for evaluating disease management, exploring the reasons for undertaking evaluation in the first place and explaining some of the underlying principles for doing so; (ii) the methods and metrics for evaluating disease management, focusing specifically on themes that have emerged as being pertinent to work carried out within the DISMEVAL project; (iii) practical considerations for disease management evaluation, based on experience of work undertaken in DISMEVAL; and (v) the broader challenges and lessons learned that may be relevant for policymakers, funders and practitioners interested in the use and usefulness of disease management evaluation more generally. This publication provides a major resource to guide the evaluation of disease management interventions in European settings and so contributes to strengthening the evidence-base required to inform the selection of efficient and effective interventions to address the growing burden of chronic disease in Europe.
- Copyright: RAND Corporation and DISMEVAL Consortium
- Publisher: RAND Corporation
- Availability: Web-Only
- Pages: 100
- Document Number: TR-1213-EC
- Year: 2012
- Series: Technical Reports
The context for evaluating chronic disease management
Methods and metrics for evaluation: experiences from the DISMEVAL project
Practical considerations for evaluation
Challenges and lessons learned
Going forward: Conclusions and further research
Summary overview of six DISMEVAL work packages on disease management evaluation methods and metrics
Evaluation measures for disease management (DM) interventions
The reseach described in this document was prepared for the European Commission on behalf of the DISMEVAL Consortium and conducted by RAND Europe.
This report is part of the RAND Corporation technical report series. RAND technical reports may include research findings on a specific topic that is limited in scope or intended for a narrow audience; present discussions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; or deliver preliminary findings. All RAND reports undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.